Truist lowers Accenture target to $150 after guidance cut
Accenture plc shares plummeted 18.5% after the company cut its fiscal 2026 revenue growth forecast to 3-4% and reported Q3 revenue of $18.72 billion, missing estimates. Analysts from TD Cowen, Truist Securities, Morgan Stanley, RBC Capital, Guggenheim, Susquehanna, and Evercore ISI all lowered their price targets, with Truist reducing its target to $150. The company updated its full-year guidance, projecting GAAP EPS of $13.38 to $13.50 and free cash flow of $10.8 billion to $11.5 billion.

*this image is generated using AI for illustrative purposes only.
Accenture plc shareholders lost approximately 18.5% of their investment value on June 18, 2026, after the company slashed its fiscal year 2026 revenue growth forecast to 3-4%, down from the 3-5% range it had previously provided. The guidance cut followed the release of fiscal third-quarter results where revenue of $18.72 billion missed analyst expectations of $18.78 billion, leading to the stock's largest single-day percentage decline on record. Law firm SueWallSt has initiated an investigation into whether Accenture made materially false or misleading statements regarding its business outlook and revenue growth projections. TD Cowen analyst Bryan Bergin downgraded Accenture from Buy to Hold and lowered the price target to $150 from $258 following the report. Truist Securities analyst Arvind Ramnani maintains Accenture with a Hold and lowers the price target from $210 to $150.
The investigation centers on Accenture's prior guidance issued during its fiscal Q2 earnings report on March 19, 2026, which projected 3-5% revenue growth for full-year fiscal 2026, an uplift from Q1's previous 2-5% target. The firm is examining whether officers and directors failed to disclose that headwinds were already pressuring the business before the outlook revision. Separately, Morgan Stanley analyst James Faucette maintains Accenture with an Equal-Weight rating and lowered the price target to $130 from $177. RBC Capital analyst David Paige maintains Accenture with an Outperform rating and lowered the price target to $175 from $253. Guggenheim analyst Jonathan Lee maintains Accenture with a Buy rating and lowered the price target to $185 from $225. Susquehanna analyst James Friedman maintains Accenture with a Neutral rating and lowered the price target to $140 from $186. Evercore ISI Group analyst David Togut maintained an Outperform rating on Accenture but lowered the price target to $180 from $250.
Third Quarter Fiscal 2026 Key Metrics
The following table summarizes Accenture's key financial metrics for the third quarter of fiscal 2026:
| Metric: | Value |
|---|---|
| New Bookings: | $19.32 billion |
| Revenues: | $18.72 billion |
| Operating Margin: | 17.0% |
| Diluted EPS: | $3.80 |
| Free Cash Flow: | $3.60 billion |
| Cash Returned to Shareholders: | $2.2 billion |
Total cash returned to shareholders amounted to $2.2 billion, reflecting share repurchases or redemptions of 6.0 million shares and cash dividend payments of $1.0 billion, or $1.63 per share. The dividend per share represented a 10% increase. Accenture ended the quarter with $10.2 billion in cash and cash equivalents.
Fiscal 2026 Business Outlook
Accenture narrowed its revenue growth expectations to 3% to 4% in local currency. The company narrowed its revenue guidance range to $71.763 billion to $72.460 billion from its previous range of $71.763 billion to $73.157 billion. The updated outlook fell below analysts' estimate of $74.006 billion. Excluding an estimated 1% impact from its U.S. federal business, the company anticipates revenue growth of 4% to 5% in local currency. The following table outlines the updated full-year guidance:
| Outlook Metric: | Guidance |
|---|---|
| Revenue Growth (Local Currency): | 3% to 4% |
| Revenue Growth ex-U.S. Federal (Local Currency): | 4% to 5% |
| GAAP Diluted EPS: | $13.38 to $13.50 (10% to 11% increase) |
| Adjusted EPS: | $13.78 to $13.90 (7% to 8% increase) |
| Free Cash Flow: | $10.8 billion to $11.5 billion |
The company increased its adjusted earnings forecast to $13.78 to $13.90 per share from $13.65 to $13.90. Accenture also increased its expected fiscal 2026 capital return to at least $9.5 billion, up from its previous forecast of at least $9.3 billion. For the fourth quarter, Accenture projects sales of $17.750 billion to $18.400 billion, compared to an analyst estimate of $18.474 billion.
How will the ongoing investigation by SueWallSt impact investor confidence and Accenture's ability to attract new clients?
What specific headwinds are causing the slowdown in the U.S. federal business, and are they expected to persist?
Will Accenture adjust its capital allocation strategy, such as share buybacks, given the revised revenue outlook?























